FDA
-
-
-
-
-
-
-
H. pylori Infections Market in the 6MM to Observe Stupendous Growth at a CAGR of 9.5% During the Forecast Period (2026-2036) | DelveInsight
-
-
-
-
-
-
-
Phathom Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Phathom Pharmaceuticals (PHAT) Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA Tablets through May 3, 2032
-
-
-
-
-
-
-
Phathom Pharmaceuticals Inc. (PHAT) : Actor and Comedian Kenan Thompson Teams Up with Phathom Pharmaceuticals to Raise Awareness About GERD and VOQUEZNA
-
-
-
-
-
-
-
Phathom Pharmaceuticals Submits Citizen Petition to FDA Seeking Correction of Orange Book Listings for VOQUEZNA® (vonoprazan) Tablets
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Phathom Pharmaceuticals (PHAT)
-
-
-
-
-
-
-
Phathom Pharmaceuticals (PHAT) Announces VOQUEZNA Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies
-
328,282 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

